Induced Neural Stem Cell Reprogramming via Single Sox2 Factor
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for methods to generate multipotent neural stem cells (NSCs) from somatic cells, as existing techniques often require multiple exogenous induction factors and specific conditions.
Innovation Solution
An in vitro method involving the introduction of a single exogenous Sox2 polypeptide into somatic cells, followed by culturing on a protein-coated solid substrate, generates induced neural stem cells (iNSCs) without the need for additional induction factors like Oct-3/4, c-Myc, Klf4, Nanog, or Lin28.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If multiple exogenous induction factors (Oct-3/4, c-Myc, Klf4, Nanog, Lin28) are introduced into somatic cells, then reprogramming efficiency is improved, but process complexity and risk of harmful effects increase
Solution Approach 1:
The patent extracts and identifies Sox2 as the critical induction factor from the complex mixture of multiple factors (Oct-3/4, c-Myc, Klf4, Nanog, Lin28). By taking out only the essential Sox2 factor, the method achieves effective reprogramming while eliminating the complexity and potential harmful effects associated with introducing multiple exogenous factors simultaneously.
Solution Approach 2:
The method utilizes the cell's endogenous transcriptional network that can be activated by Sox2 alone. The Sox2-induced reprogramming process leverages the cell's own regulatory mechanisms and existing transcription factors to complete the conversion to neural stem cells, rather than relying on continuous external input of multiple factors.
2Adaptability or versatility
If multiple exogenous induction factors are used, then reprogramming capability is enhanced, but safety and tumorigenicity concerns worsen
Solution Approach 1:
The patent extracts Sox2 as the sole necessary factor for neural stem cell reprogramming, removing the oncogenic factors (c-Myc, Klf4, Lin28) and other complex factors (Oct-3/4, Nanog) that pose tumorigenicity risks. This extraction approach maintains reprogramming capability while eliminating safety concerns associated with multiple exogenous factors.
Solution Approach 2:
The method converts the potential harm of exogenous factor introduction into benefit by selectively using only Sox2, which has demonstrated neural-specific reprogramming capability without the oncogenic side effects. The approach transforms the safety issue into an advantage by achieving reprogramming through a single, safer factor.
3Device complexity
If Sox2 is introduced as the single exogenous induction factor, then process simplicity is improved, but reprogramming efficiency may worsen
Solution Approach 1:
The Sox2-induced reprogramming method activates the cell's endogenous neural differentiation pathways and transcriptional networks. By leveraging the cell's own regulatory machinery and existing transcription factors, Sox2 alone can drive efficient reprogramming without requiring additional exogenous factors, thus maintaining both simplicity and efficiency.
Solution Approach 2:
The patent optimizes specific parameters including Sox2 expression levels, culture conditions, and time course to achieve high reprogramming efficiency with Sox2 alone. By carefully controlling these parameters, the method compensates for the reduced factor complexity while maintaining or enhancing reprogramming productivity.
4Adaptability or versatility
If somatic cells are reprogrammed to pluripotent stem cells, then cellular versatility is improved, but need for multiple induction factors increases complexity
Solution Approach 1:
The patent segments the reprogramming process into specific lineage-directed differentiation (neural stem cells) rather than attempting to achieve broad pluripotency. This segmentation allows for simpler, more targeted reprogramming using Sox2 alone, avoiding the need for multiple factors required for comprehensive pluripotent reprogramming while still achieving functional versatility within the neural lineage.
Data Source
AI summary
The present disclosure provides methods of generating neural stem cells from differentiated somatic cells. The present disclosure also provides induced neural stem cells generated using a subject method, as well as differentiated cells generated from a subject induced neural stem cell. A subject neural stem cell, as well as differentiated cells derived from a subject neural stem cell, is useful in various applications, which are also provided in the present disclosure.